Name | 1-hydroxyanthraquinone |
Synonyms | NSC 8640 HSDB 7145 CCRIS 3694 BRN 1912751 NISTC129431 1-Hydroxyanthrachinon 1-Hydroxyanthraquinone 1-hydroxyanthraquinone 1-HYDROXYANTHRAQUINONE 4-HYDROXYANTHRAQUINONE erythroxyanthraquinone Anthraquinone, 1-hydroxy- 1-Hydroxy-9,10-anthraquinone 1-hydroxy-10-anthracenedione 1-Hydroxyanthrachinon [Czech] 1-hydroxy-9,10-anthracenedione 10-Anthracenedione,1-hydroxy-9 1-hydroxyanthracene-9,10-dione 9,10-Anthracenedione, 1-hydroxy- |
CAS | 129-43-1 |
EINECS | 204-946-7 |
InChI | InChI=1/C14H8O3/c15-11-7-3-6-10-12(11)14(17)9-5-2-1-4-8(9)13(10)16/h1-7,15H |
Molecular Formula | C14H8O3 |
Molar Mass | 224.21 |
Density | 1.2337 (rough estimate) |
Melting Point | 194°C |
Boling Point | 325.61°C (rough estimate) |
Flash Point | 218.8°C |
Vapor Presure | 1.79E-07mmHg at 25°C |
Appearance | Red-orange to fine yellow crystals |
Color | Light yellow to Brown |
pKa | 7.15±0.20(Predicted) |
Storage Condition | Inert atmosphere,Room Temperature |
Refractive Index | 1.5400 (estimate) |
MDL | MFCD00058946 |
Hazard Symbols | Xn - Harmful |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R40 - Limited evidence of a carcinogenic effect R36 - Irritating to the eyes |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
RTECS | CB7178000 |
Reference Show more | 1. [IF=5.64] Zhi-Man Song et al."Anthraquinones as Potential Antibiofilm Agents Against Methicillin-Resistant Staphylococcus aureus."Front Microbiol. 2021; 12: 709826 |
NIST chemical information | Information provided by: webbook.nist.gov (external link) |
(IARC) carcinogen classification | 2B (Vol. 82) 2002 |
EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
biological activity | 1-Hydroxyanthraquinone is a natural product with oral activity, which can be derived from some plants such as Tabebuia avellanedae and has carcinogenic effects. |
Animal Model: | Thirty rats. |
Dosage: | 1% HA in diet. |
Administration: | Diet. |
Result: | Associated with decreased weight gain which was particularly marked towards the termination of experiment. One of the 30 rats in group 1 (experimental group) died of pneumonia 243 days after the start of experiment. A second rat died in an unnourished state at day 280, demonstrating a large tumor in the colon. Seven animals of the group died spontaneously or were sacrificed upon becoming moribund between 335 and 462 days. A total of 21 rats of group 1 survived until the end of experiment (mean value of total intake of HA/rat was 76.8 g). |
toxic substance data | information provided by: pubchem.ncbi.nlm.nih.gov (external link) |